Related Experiment Video
Updated: Aug 16, 2025

10:03
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
Published on: November 18, 2022
1.9K
Genetic Engineering of Immune Evasive Stem Cell-Derived Islets
Sara D Sackett1, Samuel J Kaplan2,3, Samantha A Mitchell1
1Division of Transplantation, Department of Surgery, UW Transplant Center, School of Medicine and Public Health, University of Wisconsin, Madison, WI, United States.
Summary
Genome editing advances regenerative medicine by creating immune-evasive stem cell therapies. Modifying human pluripotent stem cell-derived islets aims to prevent immune rejection in transplantation.
Area of Science:
- Regenerative Medicine
- Immunology
- Genetics
Background:
- Genome editing offers revolutionary potential in biology and medicine.
- A key application is generating immune-evasive stem cell therapies for transplantation.
- Human pluripotent stem cell-derived islets (SCDI) are increasingly studied for therapeutic benefit.
Purpose of the Study:
- To investigate the immunogenicity of stem cell-derived islets.
- To explore genome editing strategies for modulating immune responses against these cells.
- To enhance the survival of stem cell-derived islets in transplantation models.
Main Methods:
- Utilizing genome engineering technologies to modify human pluripotent stem cells.
- Eliminating Human Leukocyte Antigen (HLA) expression on stem cell-derived islets.
- Overexpressing immunomodulatory genes in stem cell progeny.
Main Results:
- Experimental work suggests HLA elimination and gene overexpression impact stem cell survival.
- Ongoing research focuses on stem cell-derived islets, with rapid progress in genome editing.
- Strategies aim to evade immune system destruction in transplantation.
Conclusions:
- Genome editing combined with stem cell therapy shows profound future impact on transplantation medicine.
- Further research is needed, but immune evasion is critical for therapeutic success.
- Modulating immune responses is key for successful stem cell-based therapies.

